Abstract: The invention is designed to enhance mammalian reproduction and in particular to improve the use of existing artificial insemination catheters in combination with novel products and processes for the insemination of mammals such as pigs. The invention comprises a controlled/sustained release delivery system comprising a metabolite/carrier combination based on specific gels, polymers and/or other molecular complexes for metabolite delivery at the point of insemination en order to promote aspects of spermatozoa function.

Abstract: A process for producing a sterile foam for medical or veterinary use is provided. A physiologically acceptable formulation for application to a body as a foam contains a foamable gelling agent. The formulation is foamed and treated with a precipitant which is calcium citrate or a calcium ion. The precipitant is combined with the foamable gelling agent before or during the foaming of the gelling agent. The foam thus obtained is allowed to cure and is then immersed in a bath of the precipitant. The treated foam is dried and sterilized by exposure to gamma-irradiation or ethylene oxide.

Abstract: A composition for a water soluble glass is described. The composition is unusual in that it contains no or very small quantities (up to 5 mole %) of alkali metal compounds. The composition typically comprises: P2O5: 30 to 60 mole %; CaO: 20 to 35 mole %; MgO: 15 to 25 mole %; ZnO: 0 to 10 mole %; and optionally may contain: Ag2O or Ag2O3: 0 to 5 mole %; and/or total alkali metal compounds (e.g. Na2O and/or K2O): 0 to 5 mole %. The composition is especially suitable for processing into water soluble glass fibers or wool.

Abstract: A composition for a water soluble glass is described. The composition is unusual in that it contains no or very small quantities (up to 5 mole %) of alkali earth metal compounds. The composition typically comprises P2O5: 40 to 60 mole %; B2O3: 0 to 10 mole %; Na2O: 30 to 40 mole %; K2O: 5 to 10 mole %; Ag2O: 0 to 5 mole %; and up to a total of 5 mole % of other compounds such as CaO, MgO etc. The composition is especially suitable for processing into water soluble glass fibers or wool since the melting point is very low, usually less than 350° C.

Abstract: A composition suitable for implantation in soft tissue (for example at or around a body orifice) in order to augment the volume of soft tissue is produced. The particles, which are desirably irregularly shaped, are formed from a biodegradable phosphate glass, and may have an average particle diameter of 50 &mgr;m to 2000 &mgr;m, preferably 50 &mgr;m to 300 &mgr;m. The particles are used with a carrier medium for injection into soft tissue such as the bladder submucosa. This procedure can be applied to treat conditions such as vesicoureteric reflux. Additionally the procedure could be used cosmetically.

Abstract: A packaging system which comprises a first container (24) having a valve (27) controlling the opening of an outlet and which contains a first ingredient (25), and a second container (28) having an openable entry portion (14) and containing a second ingredient (29). The packaging system further comprises means for connecting the first and second containers together in order to allow said first ingredient to be displaced from the first container into the second container via the entry portion thereof, so that said first and second ingredients are admixed in said second container to form a final product.

Abstract: There is described a foamable formulation comprising a foamable carrier and an active ingredient which may be admixed with the carrier or packaged separately and dispersed into the carrier during the foaming process. Alginate gel is a preferred foamable carrier. The foam produced from such a formulation, and a foam sheet produced by drying the foam, also form part of the invention. The formulation, foam and foam sheet are especially useful for medical applications, for example in treating burns. As apparatus to store the components of the formulation and to generate the foam is also described.

Abstract: There is provided an antimicrobial composition for combatting infections. The material is a controlled release glass having two or more agents selected from the group consisting of metals, selenium and boron. Preferably the agents are selected from the group consisting of copper, silver, magnesium, zinc, cerium,consisting of copper, silver, magnesium, zinc, cerium, manganese bismuth, selenium and boron. The combinations of copper and silver and of copper and zinc are particularly preferred and exhibit synergist activity. The antimicrobial composition is effective against infections due to Proteus spp.

Abstract: A medical film dressing comprising a thin transparent film having a layer of skin adhesive on its front face, shielded before use by a removable cover sheet in contact which is in contact with the adhesive across the entire area of the front face, and a backing sheet detachably affixed over the whole of the rear face of said film. The dressing further comprises a flexible hinge in the form of a folded strip disposed along a peripheral edge of said thin film to conjoin said cover sheet and said backing sheet adjacent said edge, and extending around the corresponding edge of the thin film, and wherein a scoreline is formed in said cover sheet. The score line extends parallel to the edge of the dressing opposite the hinge and wherein the line of perforation extends through said thin film beneath said score line.

Abstract: There is provided a device to promote healing of cut tissue members, such as nerves, tendon or muscles, within a body. The device is of hollow construction and comprises apertures into which the cut ends of the tissue members are placed and fixed, usually by a fibrin-based tissue glue. Located between the apertures is a substance to promote healing of the tissue member such as, for example, nerve growth factor. Optionally the device may be used in conjunction with the external reservoir of the substance and/or with a time-operated pump to deliver the substance to the device. The device is biodegradable and is preferably composed of watersoluble glass.

Abstract: The invention discloses fluids for use in medical dialysis procedures which contain proteolytic hydrolysates of one or more proteins (e.g. casein) as effective osmotic agent and bicarbonate ions as buffering agent. Additionally the dialysis fluid contains physiological salts.

Abstract: A medicinal substance for topical application is disclosed. The substance comprises a water-soluble glass containing silver or a silver compound. Typically, the glass comprises phosphorus pentoxide and contains silver oxide. The substance may be used for the treatment of wounds, catheter and tubing entry points, stoma sites and body passage entrances where bacterial growth and migration are rife. The glass may be in the form of a powder, granules, woven into a dressing form, a sinter shaped in a particular way or used as filler in polymers for surface release.

Abstract: Apparatus for use in fluid flow lines to or from a living body in order to reduce the incidence or growth of bacteria comprising in the flow line a connecting member which includes water-soluble silver impregnated glass, whereby the glass undergoes slow dissolution with concomitant release of silver into the fluid. The silver has antibacterial or bacterial static properties.